 Melkon DomBourian
Concepts (103)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood Component Removal | 1 | 2021 | 26 | 0.680 |
Why?
| | Reagent Kits, Diagnostic | 1 | 2020 | 34 | 0.640 |
Why?
| | Clinical Laboratory Techniques | 1 | 2020 | 96 | 0.610 |
Why?
| | Betacoronavirus | 1 | 2020 | 286 | 0.520 |
Why?
| | Plasma | 2 | 2020 | 223 | 0.450 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 387 | 0.440 |
Why?
| | Coronavirus Infections | 1 | 2020 | 381 | 0.440 |
Why?
| | Methemoglobinemia | 1 | 2015 | 13 | 0.440 |
Why?
| | Cyanosis | 1 | 2015 | 17 | 0.440 |
Why?
| | Antibodies, Viral | 5 | 2021 | 672 | 0.430 |
Why?
| | Cannabis | 1 | 2021 | 509 | 0.410 |
Why?
| | Blood Component Transfusion | 1 | 2012 | 104 | 0.330 |
Why?
| | Infusions, Intravenous | 1 | 2012 | 422 | 0.330 |
Why?
| | Antigens, Viral | 2 | 2021 | 182 | 0.310 |
Why?
| | Antibodies, Neutralizing | 3 | 2021 | 341 | 0.310 |
Why?
| | Blood Donors | 2 | 2021 | 143 | 0.300 |
Why?
| | Receptor, Bradykinin B1 | 1 | 2006 | 2 | 0.250 |
Why?
| | Nociceptors | 1 | 2006 | 40 | 0.250 |
Why?
| | Immunoglobulin G | 2 | 2021 | 886 | 0.240 |
Why?
| | TRPV Cation Channels | 1 | 2006 | 43 | 0.240 |
Why?
| | Euthyroid Sick Syndromes | 1 | 2026 | 6 | 0.240 |
Why?
| | Thyrotropin | 1 | 2026 | 119 | 0.230 |
Why?
| | Hyperalgesia | 1 | 2006 | 132 | 0.230 |
Why?
| | Thyroid Gland | 1 | 2026 | 88 | 0.230 |
Why?
| | Spike Glycoprotein, Coronavirus | 3 | 2021 | 130 | 0.230 |
Why?
| | Transfusion Medicine | 1 | 2025 | 16 | 0.220 |
Why?
| | Immunoassay | 2 | 2021 | 105 | 0.200 |
Why?
| | Peripheral Blood Stem Cells | 1 | 2022 | 4 | 0.190 |
Why?
| | Spinal Cord Injuries | 1 | 2006 | 240 | 0.190 |
Why?
| | Nerve Tissue Proteins | 1 | 2006 | 590 | 0.190 |
Why?
| | Blood Transfusion | 1 | 2025 | 405 | 0.180 |
Why?
| | Patient Safety | 1 | 2025 | 353 | 0.170 |
Why?
| | Convalescence | 1 | 2021 | 19 | 0.170 |
Why?
| | Emergency Responders | 1 | 2021 | 37 | 0.160 |
Why?
| | Nucleocapsid Proteins | 1 | 2020 | 28 | 0.160 |
Why?
| | Serologic Tests | 1 | 2020 | 53 | 0.160 |
Why?
| | Immunization, Passive | 1 | 2020 | 88 | 0.160 |
Why?
| | Sensitivity and Specificity | 2 | 2021 | 1995 | 0.140 |
Why?
| | Hematologic Neoplasms | 1 | 2021 | 163 | 0.140 |
Why?
| | Phosphoproteins | 1 | 2020 | 339 | 0.140 |
Why?
| | Pediatrics | 1 | 2025 | 1121 | 0.120 |
Why?
| | RNA, Viral | 1 | 2020 | 689 | 0.120 |
Why?
| | Down Syndrome | 1 | 2022 | 522 | 0.110 |
Why?
| | Methemoglobin | 1 | 2015 | 24 | 0.110 |
Why?
| | Pandemics | 2 | 2021 | 1700 | 0.110 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2021 | 677 | 0.110 |
Why?
| | Blood Gas Analysis | 1 | 2015 | 81 | 0.110 |
Why?
| | Colorado | 2 | 2021 | 4558 | 0.100 |
Why?
| | Platelet Transfusion | 1 | 2015 | 78 | 0.100 |
Why?
| | Humans | 14 | 2026 | 144667 | 0.100 |
Why?
| | Thrombocytopenia | 1 | 2015 | 202 | 0.090 |
Why?
| | Child | 4 | 2025 | 22600 | 0.080 |
Why?
| | Surveys and Questionnaires | 1 | 2021 | 6041 | 0.070 |
Why?
| | Pregnancy | 1 | 2021 | 7122 | 0.070 |
Why?
| | Neoplasms | 2 | 2021 | 2873 | 0.070 |
Why?
| | Laminectomy | 1 | 2006 | 31 | 0.060 |
Why?
| | Contusions | 1 | 2006 | 25 | 0.060 |
Why?
| | Thyroid Function Tests | 1 | 2026 | 19 | 0.060 |
Why?
| | Triiodothyronine | 1 | 2026 | 54 | 0.060 |
Why?
| | Hindlimb | 1 | 2006 | 131 | 0.060 |
Why?
| | Thyroxine | 1 | 2026 | 65 | 0.060 |
Why?
| | Models, Animal | 1 | 2006 | 393 | 0.050 |
Why?
| | Reaction Time | 1 | 2006 | 438 | 0.050 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 973 | 0.050 |
Why?
| | Young Adult | 1 | 2021 | 14122 | 0.050 |
Why?
| | Decision Making | 1 | 2012 | 973 | 0.050 |
Why?
| | Pain Measurement | 1 | 2006 | 554 | 0.050 |
Why?
| | Hot Temperature | 1 | 2006 | 410 | 0.050 |
Why?
| | Infant, Newborn | 1 | 2015 | 6399 | 0.050 |
Why?
| | Hematopoietic Stem Cell Mobilization | 1 | 2022 | 27 | 0.050 |
Why?
| | Antigens, CD34 | 1 | 2022 | 88 | 0.050 |
Why?
| | Male | 5 | 2026 | 72431 | 0.050 |
Why?
| | Blood Volume | 1 | 2022 | 65 | 0.050 |
Why?
| | Blood Cell Count | 1 | 2022 | 55 | 0.050 |
Why?
| | Leukocyte Count | 1 | 2022 | 315 | 0.040 |
Why?
| | Adolescent | 1 | 2021 | 22409 | 0.040 |
Why?
| | Bone Marrow Transplantation | 1 | 2022 | 293 | 0.040 |
Why?
| | Adult | 2 | 2022 | 40489 | 0.040 |
Why?
| | Cross Reactions | 1 | 2021 | 130 | 0.040 |
Why?
| | Rats, Sprague-Dawley | 1 | 2006 | 2521 | 0.040 |
Why?
| | Reference Values | 1 | 2022 | 794 | 0.040 |
Why?
| | Vero Cells | 1 | 2021 | 84 | 0.040 |
Why?
| | Microspheres | 1 | 2021 | 142 | 0.040 |
Why?
| | Seroepidemiologic Studies | 1 | 2021 | 171 | 0.040 |
Why?
| | Cell- and Tissue-Based Therapy | 1 | 2021 | 78 | 0.040 |
Why?
| | Female | 3 | 2026 | 78304 | 0.040 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 835 | 0.040 |
Why?
| | Rats | 1 | 2006 | 5570 | 0.030 |
Why?
| | Gene Expression Regulation | 1 | 2006 | 2591 | 0.030 |
Why?
| | Risk Factors | 1 | 2012 | 10796 | 0.030 |
Why?
| | Immunotherapy, Adoptive | 1 | 2021 | 339 | 0.030 |
Why?
| | Electronic Health Records | 1 | 2025 | 1176 | 0.030 |
Why?
| | Inflammation | 1 | 2006 | 2870 | 0.030 |
Why?
| | Platelet Count | 1 | 2015 | 94 | 0.030 |
Why?
| | Prospective Studies | 1 | 2026 | 7994 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2021 | 3414 | 0.020 |
Why?
| | Animals | 2 | 2021 | 37948 | 0.020 |
Why?
| | Blood Platelets | 1 | 2015 | 379 | 0.020 |
Why?
| | Time Factors | 1 | 2021 | 7140 | 0.020 |
Why?
| | Hemorrhage | 1 | 2015 | 813 | 0.020 |
Why?
| | Aged | 1 | 2026 | 25955 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2022 | 17149 | 0.010 |
Why?
| | Middle Aged | 1 | 2026 | 35971 | 0.010 |
Why?
|
|
DomBourian's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|